WNT6 is a novel oncogenic prognostic biomarker in human glioblastoma

Glioblastoma (GBM) is a universally fatal brain cancer, for which novel therapies targeting specific underlying oncogenic events are urgently needed. While the WNT pathway has been shown to be frequently activated in GBM, constituting a potential therapeutic target, the relevance of WNT6, an activat...

ver descrição completa

Detalhes bibliográficos
Autor principal: Gonçalves, Céline S. (author)
Outros Autores: Castro, Joana Isabel Martins Cosme Vieira (author), Pojo, Marta (author), Martins, Eduarda P. (author), Queirós, Sandro Filipe Monteiro (author), Chautard, Emmanuel (author), Taipa, Ricardo (author), Pires, Manuel Melo (author), Pinto, Afonso A. (author), Pardal, Fernando (author), Custódia, Carlos (author), Faria, Cláudia C. (author), Clara, Carlos (author), Reis, R. M. (author), Sousa, Nuno (author), Costa, Bruno Marques (author)
Formato: article
Idioma:eng
Publicado em: 2018
Assuntos:
biomarker
glioblastoma
oncogene
prognosis
WNT6
WNT pathway
Ciências Médicas::Medicina Básica
Science & Technology
Texto completo:http://hdl.handle.net/1822/57857
País:Portugal
Oai:oai:repositorium.sdum.uminho.pt:1822/57857

Texto Completo

http://hdl.handle.net/1822/57857

Registos relacionados